| Financial Year |
March 31 2023 |
| Monetary Funds |
1,837,084,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
8,995,299,000.00 |
| Advances to Suppliers |
574,589,000.00 |
| Other Receivables |
3,221,467,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
540,000.00 |
| Inventories |
1,868,644,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,621,202,000.00 |
| Total Current Assets |
38,081,685,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,459,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
24,118,200,000.00 |
| Under-construction Projects |
480,879,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
440,362,000.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,729,090,000.00 |
| Deferred Income Tax Assets |
367,535,000.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
33,309,155,000.00 |
| Total Assets |
71,390,840,000.00 |
| Short-Term Loans |
19,078,567,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,029,108,000.00 |
| Accounts Payable |
24,155,637,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
675,313,000.00 |
| Taxes Payable |
745,417,000.00 |
| Interest Payable |
16,500,000.00 |
| Dividend Payable |
-- |
| Other payables |
2,845,258,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,498,895,000.00 |
| Other Current Liabilities |
12,000.00 |
| Sub-Total of Current Liabilities |
62,349,469,000.00 |
| Long-term Loans |
453,532,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
92,783,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
193,801,000.00 |
| Deferred Income Tax Liabilities |
74,399,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,272,573,000.00 |
| Total Liabilities |
63,622,042,000.00 |
| Paid-In Capital(Or Share Stock) |
18,984,340,000.00 |
| Capital Surplus |
11,717,773,000.00 |
| Surplus Reserve |
200,383,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-23,659,863,000.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,768,798,000.00 |
| Owner's Equity（Stockholder's Equity） |
7,768,798,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
71,390,840,000.00 |
